Target intelligence / Profile preview

Expanded CUG repeats in DMPK mRNA (CUGexp)

Target
CUGexp
Molecular classification
Toxic RNA, Microsatellite repeat expansion, mRNA
01

Overview

Pathogenic expanded CUG repeats in the 3' untranslated region (UTR) of the Dystrophia Myotonica Protein Kinase (DMPK) mRNA are the primary molecular drivers of Myotonic Dystrophy Type 1 (DM1). These expansions, typically exceeding 50 repeats and often reaching thousands, adopt stable hairpin secondary structures that aggregate into ribonuclear foci within the cell nucleus. These foci sequester essential RNA-binding proteins, most notably the Muscleblind-like (MBNL) family, which are critical for regulating alternative splicing across hundreds of genes. The resulting loss of functional MBNL leads to a global spliceopathy, causing the multisystemic symptoms of DM1, such as myotonia, muscle wasting, and cardiac conduction defects. Therapeutic strategies focus on reducing the levels of this toxic RNA using antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) to trigger its degradation, or small molecules to displace sequestered proteins. Successful intervention aims to restore normal splicing patterns and alleviate the clinical manifestations of the disease.

Other names
Toxic CUG repeatsr(CUG)expExpanded DMPK mRNACUG repeat expansionMutant DMPK mRNA
02

Mechanism of action

RNase H-mediated RNA degradation; RNA interference (RNAi); Steric blocking of RNA-binding proteins; Inhibition of transcription

03

Biological functions

RNA sequestrationRegulation of alternative splicingRNA foci formationRNA-binding protein sequestration
04

Disease associations

Myotonic dystrophy type 1
05

Safety considerations

Potential toxicity from wild-type DMPK knockdownOff-target RNA bindingDelivery challenges to skeletal and cardiac muscleImmunogenicity of antibody-oligonucleotide conjugates
06

Interacting drugs

Delpacibart etedesiran (AOC 1001)

4 more in the full profile.

07

Biomarkers

CLCN1 splicing correctionINSR splicing correctionBIN1 splicing correctionDMPK mRNA levelsNuclear ribonuclear foci countFunctional MBNL1 levels

Beyond the preview

Go deeper on Expanded CUG repeats in DMPK mRNA (CUGexp).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Expanded CUG repeats in DMPK mRNA (CUGexp).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call